The potential role of microRNA-mediated motor neuron-muscle pathologic interactions in amyotrophic lateral sclerosis.
作者信息
Ueno Yuji, Nakamura Yuki, Hata Takanori
机构信息
Department of Neurology, University of Yamanashi, Chuo, Japan.
出版信息
Mol Ther Nucleic Acids. 2025 Aug 23;36(3):102675. doi: 10.1016/j.omtn.2025.102675. eCollection 2025 Sep 9.
Abstract
摘要
相似文献
1
The potential role of microRNA-mediated motor neuron-muscle pathologic interactions in amyotrophic lateral sclerosis.
Mol Ther Nucleic Acids. 2025 Aug 23;36(3):102675. doi: 10.1016/j.omtn.2025.102675. eCollection 2025 Sep 9.
2
WITHDRAWN: Amino acids for amyotrophic lateral sclerosis / motor neuron disease.
Cochrane Database Syst Rev. 2008 Apr 16(2):CD003457. doi: 10.1002/14651858.CD003457.pub2.
3
Amino acids for amyotrophic lateral sclerosis / motor neuron disease.
Cochrane Database Syst Rev. 2003(4):CD003457. doi: 10.1002/14651858.CD003457.
4
Neurophysiological and imaging biomarkers of lower motor neuron dysfunction in motor neuron diseases/amyotrophic lateral sclerosis: IFCN handbook chapter.
Clin Neurophysiol. 2024 Jun;162:91-120. doi: 10.1016/j.clinph.2024.03.015. Epub 2024 Mar 20.
5
Ciliary neurotrophic factor (CNTF) for amyotrophic lateral sclerosis/motor neuron disease.
Cochrane Database Syst Rev. 2004;2004(3):CD004302. doi: 10.1002/14651858.CD004302.pub2.
6
Latest progress and challenges in drug development for degenerative motor neuron diseases.
Neural Regen Res. 2025 May 6. doi: 10.4103/NRR.NRR-D-24-01266.
7
Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease.
Cochrane Database Syst Rev. 2004(1):CD004156. doi: 10.1002/14651858.CD004156.pub2.
8
A systematic review of antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease.
Amyotroph Lateral Scler. 2008 Aug;9(4):195-211. doi: 10.1080/17482960801900032.
9
How do we get from hyperexcitability to excitotoxicity in amyotrophic lateral sclerosis?
Brain. 2024 May 3;147(5):1610-1621. doi: 10.1093/brain/awae039.
10
Novel approaches to assessing upper motor neuron dysfunction in motor neuron disease/amyotrophic lateral sclerosis: IFCN handbook chapter.
Clin Neurophysiol. 2024 Jul;163:68-89. doi: 10.1016/j.clinph.2024.04.010. Epub 2024 Apr 18.
本文引用的文献
1
Restoration of myogenesis in ALS-myocytes through miR-26a-5p-mediated Smad4 inhibition and its impact on motor neuron development.
Mol Ther Nucleic Acids. 2025 May 30;36(3):102581. doi: 10.1016/j.omtn.2025.102581. eCollection 2025 Sep 9.
2
Current progress in microRNA profiling of circulating extracellular vesicles in amyotrophic lateral sclerosis: A systematic review.
Neurobiol Dis. 2024 Oct 1;200:106639. doi: 10.1016/j.nbd.2024.106639. Epub 2024 Aug 19.
3
SOD1 Astrocyte-Derived Extracellular Vesicles Induce Motor Neuron Death by a miRNA-155-5p-Mediated Mechanism.
ASN Neuro. 2023 Jan-Dec;15:17590914231197527. doi: 10.1177/17590914231197527.
4
Skeletal muscle in amyotrophic lateral sclerosis.
Brain. 2023 Nov 2;146(11):4425-4436. doi: 10.1093/brain/awad202.
5
Trial of Antisense Oligonucleotide Tofersen for ALS.
N Engl J Med. 2022 Sep 22;387(12):1099-1110. doi: 10.1056/NEJMoa2204705.
6
miR126-5p Downregulation Facilitates Axon Degeneration and NMJ Disruption via a Non-Cell-Autonomous Mechanism in ALS.
J Neurosci. 2018 Jun 13;38(24):5478-5494. doi: 10.1523/JNEUROSCI.3037-17.2018. Epub 2018 May 17.
7
Muscle Expression of SOD1(G93A) Modulates microRNA and mRNA Transcription Pattern Associated with the Myelination Process in the Spinal Cord of Transgenic Mice.
Front Cell Neurosci. 2015 Dec 1;9:463. doi: 10.3389/fncel.2015.00463. eCollection 2015.
8
MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice.
Science. 2009 Dec 11;326(5959):1549-54. doi: 10.1126/science.1181046.
9
Prognostic factors in ALS: A critical review.
Amyotroph Lateral Scler. 2009 Oct-Dec;10(5-6):310-23. doi: 10.3109/17482960802566824.
10
Cognitive impairment in amyotrophic lateral sclerosis.
Lancet Neurol. 2007 Nov;6(11):994-1003. doi: 10.1016/S1474-4422(07)70265-X.
Zotero 插件